PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19789415-8	2009	CONCLUSIONS: The combination of an ACEI and indapamide improved BP control, but attenuated the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension.	Indapamide	44-54	adiponectin, C1Q and collagen domain containing	Homo sapiens	142-153	
19789415-0	2009	Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension.	Indapamide	36-46	adiponectin, C1Q and collagen domain containing	Homo sapiens	146-157	
17536226-0	2007	Indapamide decreases plasma adiponectin concentration in patients with essential hypertension.	Indapamide	0-10	adiponectin, C1Q and collagen domain containing	Homo sapiens	28-39	
17536226-8	2007	However, a significant decrease of plasma adiponectin concentration (from 11.6 +/- 4.6 to 10.2 +/- 4.2 mg/l, p = 0.047) was observed in patients treated with indapamide.	Indapamide	158-168	adiponectin, C1Q and collagen domain containing	Homo sapiens	42-53	
17536226-10	2007	CONCLUSION: Treatment with indapamide was followed by a significant decrease of plasma adiponectin concentration.	Indapamide	27-37	adiponectin, C1Q and collagen domain containing	Homo sapiens	87-98